Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures.
“Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
It is time for a new New Testament. In February of 2012, a council of scholars and spiritual leaders, convened by religious scholar Hal Taussig, came together to discuss, debate, and reconsider which books belong in the New Testament. They talked about dozens of newly found texts, their lessons, and how they inform the previously bound books. Reading the existing New Testament alongside these new texts—The Gospel of Luke with The Gospel of Mary, Paul’s letters with The Letter of Peter to Philip, The Revelation to John with The Secret Revelation to John—offers the exciting possibility of understanding both—the new and the old—better. What were early Christians’ concerns? What was daily practice? What was a woman’s place? How was Jesus remembered and his message promoted? In this imaginative reframing, Taussig presents explanatory introductions and additional historical background alongside the traditional New Testament books and ten newly included scriptures, all bringing us closer to a full appreciation of these documents and their impact on spiritual life. Learn more at http://bit.ly/newnewtestament Religion
With the onset of winter season in the country, breathing problems and respiratory diseases will also be on the rise. To ensure that patients with respiratory problems breathe with ease, a comprehensive patient Mobile App named “My Breathefree” has been launched as a virtual caregiver by ‘Breathefree’, a public service initiative by Cipla. This app is specifically designed for Indian conditions and is available on Google play store and iOS platform for all patients, caregivers and doctors.
One of the major chronic respiratory problems in the country is asthma and “My Breathefree” app will be a great help towards better asthma management and control. Asthma causes limitations in daily activities, loss of school and work days, lung function impairment, reduced quality of life and an adverse socioeconomic burden. However, if monitored and treated properly, asthmatics can control their disease and lead an absolutely normal and healthy life.
To view the multimedia release go to:
http://www.multivu.com/players/English/7562351-lung-care-asthma-mobile-app/
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor. This new approach to treating blood cancers works by blocking BTK, a protein that helps certain cancer cells live and grow.1 IMBRUVICA is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), or adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy, or in first line in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762540-janssen-ec-approval-imbruvica-mcl-cll/
Extremely painful and destructive, gout is the most common form of inflammatory arthritis with elevated serum uric acid (sUA) a root cause of the disease. Even with the growing incidence of gout, recent research from the Gout & Uric Acid Education Society (GUAES) found that just 16 percent of Americans overall know the target sUA number for gout (6 mg/dL or below) – and just 38 percent of people with gout had their sUA levels checked within the past six months, the timeframe recommended by the American College of Rheumatology. Additionally, the majority of gout sufferers don’t understand the importance of taking daily uric acid-lowering medications, with four in 10 incorrectly believing that they can stop taking medications when they aren’t experiencing flares.
Seeking to increase recognition of the severity of gout and need for routine sUA testing and management, GUAES hosted a professional roundtable discussion on October 3, 2015. The roundtable brought together several experts – rheumatologists, a family care physician, and representatives from the American Association of Diabetes Educators, the National Kidney Foundation and CreakyJoints – to explore how to more effectively educate about gout and improve access to public education and treatment.
To view the multimedia release go to:
http://www.multivu.com/players/English/7715851-guaes-gout-roundtable-discussion/
During today’s Big Game, viewers will have learned that the much-talked about sequel of an ʼ80s movie, “Dundee: The Son of a Legend Returns Home”, is not a sequel at all. It is actually an elaborate, star-studded advertising campaign aimed at attracting more travelers to visit Australia.
Tourism Australia, the government agency responsible for attracting international visitors to Australia, has revealed it is behind the major US marketing campaign.
Over the past two weeks, excitement for the new Crocodile Dundee movie has been steadily building. Imitating a traditional studio promotional campaign—using PR, social, digital, OOH and the release of four teaser films—anticipation for the new film was widely reported in People, Buzzfeed, Daily Mail, Good Morning America, and the Hollywood Reporter, among others.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268251-tourism-australia-dundee/
As another school year ends, American parents once again face the challenge of making sure their kids get enough daily physical activity to keep them occupied throughout the summer. Based on the results of a recent national survey of parents with children ages 3-17, that may be easier said than done.
While the U.S. Centers for Disease Control and Prevention recommends that kids have at least 60 minutes of daily physical activity, the Let’s Play 2016 State of Play Survey, commissioned by Dr Pepper Snapple Group (NYSE: DPS), revealed that only one out of three children participates in daily active play.
There also appears to be a significant drop in daily active play when most children head off to kindergarten. Half of 4-year-olds get active daily playtime, compared to 31 percent of 5-year-olds.
To view the multimedia release go to:
http://www.multivu.com/players/English/7816051-dr-pepper-snapple-lets-play/
Oura Health, the Finnish health technology company behind the Oura ring, has moved its total private funding to 12.5M€ after the closure of a round led by US-based Bold Capital Partners and Finland’s Tesi. The funding will be used to scale US market operations and push the Oura platform forward.
The Oura ring and app guides wearers towards better sleep, recovery and readiness to perform by analyzing the body’s sleep, activity levels, daily rhythms and physiological responses.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8362451-oura-health-strengthens-position-us-market/
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
Quinny and Maxi-Cosi, premier European brands owned by Dorel Juvenile, a segment of Dorel Industries (TSX: DII.B, DII.A), and the world's largest juvenile products manufacturer in its categories, today announced the arrival of the Rachel Zoe x Quinny and Maxi-Cosi Collection, a luxurious collection of strollers, car seats and baby gear designed by Rachel Zoe. The collection, now available for purchase at Nordstrom, followed by retailers globally later this year, retails in the US from $229 to $899 and includes the Quinny® Moodd stroller, the Maxi-Cosi® Mico Max 30 and Maxi-Cosi® Pria 85 car seats, and Quinny Diaper Bag.
With nearly two decades of experience in design and fashion, Zoe has become a household name, embodying modern, effortless glamour and timeless sophistication. From designing her eponymous ready-to-wear, jewelry, and footwear collection and authoring two New York Times bestselling books, to serving as Editor-in-Chief of digital lifestyle destination The Zoe Report, Rachel’s influence reaches millions daily and continues to grow. As a mother of two young boys, Zoe’s influence also extends from fashion, beauty and style into the worlds of parenthood, home, entertaining and lifestyle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7851951-dorel-juvenile-rachel-zoe-nordstrom/
In a departure from the long-held industry tradition of feature wars, Whirlpool brand today announced the launch of Every day, care™, a campaign about changing the perception of how people view the daily chores necessary to care for one’s family. Too often these simple acts of cooking, cleaning and washing feel tedious and insignificant, when in fact they play a huge role in shaping the people we love and the world we live in.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7318751-whirlpool-announced-launch-of-every-day-take-the-chore-out-of-household-responsibilities/
What happens when Pitch Perfect actress Brittany Snow uses her charm to talk sunscreen? Shoppers end up singing a different tune than what they expected. Snow, the new face of Coppertone® CLEARLYSheer®, helps prove that trusted protection doesn’t have to come in a tiny bottle with a fancy price tag. Through hidden cameras, she delights shoppers with Coppertone® CLEARLYSheer®, the breathable and light daily sunscreen that’s perfect for everyday protection.
Most people don’t expect a luxurious moisturizing sunscreen to come from Coppertone®. To help them understand it is possible, the brand masked CLEARLYSheer® as Le Clair, a non-existent new prestige sunscreen. Coppertone® then teamed up with Brittany to encourage shoppers to test the face-friendly product on their skin. While they unknowingly applied Coppertone® CLEARLYSheer®, they continually complimented its clean and lightweight formula. At the end, the product is revealed to be from Coppertone®! Is their reaction good or bad? Check out the video to see what shoppers had to say following the reveal! Are they pleasantly surprised? Did Brittany sell it in? You’ll have to watch the video to find out.
To view the multimedia release go to:
http://www.multivu.com/players/English/7829551-coppertone-clearlysheer-brittany-snow/
